Dorsal root ganglion stimulation device explantation: A multicenter pooled data analysis.
Kenneth B ChapmanAjax YangAlon Y MogilnerNataniel MandelbergKiran V PatelTimothy R LubenowTimothy DeerJan Willem KallewaardNoud van HelmondPublished in: Pain practice : the official journal of World Institute of Pain (2022)
This large retrospective study of DRG-S revealed a low therapy-termination rate. The rate of infection leading to explantation was objectively very low at 0.4%. The leading cause of explantation was inadequate pain relief. Explanted patients often had a therapy-related complication. Therefore, minimizing adverse treatment events may reduce ultimate explantation rates.
Keyphrases
- data analysis
- neuropathic pain
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- chronic pain
- spinal cord
- physical activity
- emergency department
- stem cells
- prognostic factors
- clinical trial
- cross sectional
- mesenchymal stem cells
- combination therapy
- replacement therapy
- open label
- cell therapy
- study protocol
- double blind
- electronic health record
- adverse drug